The risk for infection in patients with antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis on immunosuppressive therapy is linked to having chronic lung disease as well as having a ...
Please provide your email address to receive an email when new articles are posted on . The findings apply specifically to patients with ANCA-associated vasculitis without severe glomerulonephritis or ...
Maintaining remission in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis who have kept their autoantibodies in check after at least 2 years on rituximab therapy has ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A growing therapeutic armamentarium for antineutrophil ...
Ellen Romich, MD, MSCE, examines associated vasculitis relapse and which markers sig examines associated vasculitis relapse ...
The FDA approved the oral complement 5a receptor inhibitor avacopan (Tavneos) for the treatment of severe, active antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, drugmaker ...
Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...
Source: Getty Images A EULAR task force revised guidelines to reflect findings from randomized clinical trials that were published since the last update in 2016. A task force of the European Alliance ...
A population-based study of Swedish adults found that ANCA-associated vasculitis is more prevalent among men than women. Despite a stable incidence of ANCA-associated vasculitis in southern Sweden, ...
Antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis, or AAV, causes inflammation of the blood vessels and can affect many parts of the body, including multiple organs. Because of this, ...
While a diagnosis of antineutrophil cytoplasmic antibodies (ANCA)–associated vasculitis, or AAV, may seem daunting, it’s important to know that this chronic autoimmune disorder is no longer the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results